| Literature DB >> 19370384 |
Daniël C J de Kam1, Jean W M Gardeniers, Jan C M Hendriks, René P H Veth, B Willem Schreurs.
Abstract
UNLABELLED: Although uncemented cup implants frequently are used in young patients, we believe long-term survival rates of cups in these patients are somewhat disappointing, and therefore we have continued to use cemented cups in primary THA, even in young patients. However, in cases of acetabular bone stock defects, we also use bone impaction grafting. We prospectively followed 130 patients with 175 cemented cups; no patients were lost to followup. The mean age of the patients at surgery was 31 years (range, 16-39 years). An acetabular reconstruction with bone impaction grafting was performed in 84 hips (48%). The minimum followup was 2 years (average, 8.1 years; range, 2.0-18.5 years). Twenty-one of the 175 cups (12%) were revised at an average of 8.1 years (range, 2.0-18.5 years). Reasons for revision were infection (one early, seven late), recurrent dislocations (two), traumatic loosening (one), and aseptic loosening (10). The 10-year survival rate of all cemented cups with end point of revision for any cause was 85%. Survival with end point of aseptic loosening of all cups was 92%. Survival with end point of revision for aseptic loosening was 90% for the cups without impaction grafting and 95% for the cups with impaction grafting. We believe cemented acetabular cups in young patients have acceptable midterm survival; however, in the case of acetabular bone defects, we recommend reconstruction with impaction grafting. LEVEL OF EVIDENCE: Level III, therapeutic study.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19370384 PMCID: PMC2690764 DOI: 10.1007/s11999-009-0837-3
Source DB: PubMed Journal: Clin Orthop Relat Res ISSN: 0009-921X Impact factor: 4.176
Indications for primary THA with and without reconstruction with bone impaction grafting
| Indication | Number of hips | ||
|---|---|---|---|
| Without bone impaction grafting | With bone impaction grafting | Total | |
| Developmental dysplasia of the hip | 10 | 32 | 42 |
| Rheumatoid arthritis | 17 | 10 | 27 |
| Perthes’ disease | 4 | 4 | 8 |
| Avascular necrosis of unknown cause | 6 | 2 | 8 |
| Epiphyseal dysplasia | 5 | 2 | 7 |
| Posttraumatic osteoarthritis | 2 | 4 | 6 |
| Bechterew’s disease | 3 | 2 | 5 |
| Posttraumatic avascular necrosis | 4 | 1 | 5 |
| Morquio’s disease | 1 | 3 | 4 |
| Epiphysiolysis | 1 | 3 | 4 |
| Septic coxitis | 2 | 1 | 3 |
| Protrusio acetabuli | 0 | 3 | 3 |
| Osteomyelitis | 0 | 3 | 3 |
| Spontaneous fusion of the hip of unknown cause | 1 | 1 | 2 |
| Osteogenesis imperfecta | 0 | 2 | 2 |
| Polycystic disease of unknown cause | 2 | 0 | 2 |
| Psoriatic arthritis | 0 | 1 | 1 |
| Gigantism of unknown cause | 0 | 1 | 1 |
| Pseudohypoparathyroidism | 1 | 0 | 1 |
| Monoarthritis of unknown cause | 0 | 1 | 1 |
| Alcohol-induced avascular necrosis | 1 | 0 | 1 |
| Corticosteroid-induced avascular necrosis | 31 | 8 | 39 |
| Systemic lupus erythematosus | 9 | ||
| Kidney transplantation/nephropathy | 7 | ||
| Subarachnoid hemorrhage | 4 | ||
| Non-Hodgkin’s lymphoma | 3 | ||
| Crohn’s disease | 3 | ||
| Cerebral aneurysm | 2 | ||
| Head trauma | 2 | ||
| Thrombocytopenia | 2 | ||
| Hypothalamus hormone substitution | 1 | ||
| Germ cell tumor | 1 | ||
| Aplastic anemia | 1 | ||
| Pituitary adenoma | 1 | ||
| Wegener’s disease | 1 | ||
| Acute lymphatic leukemia | 1 | ||
| Meduloblastoma | 1 | ||
| Total | 91 | 84 | 175 |
Outcome of clinical questionnaires
| Questionnaire | Preoperative score | Postoperative score | ||||
|---|---|---|---|---|---|---|
| With bone impaction grafting | Without bone impaction grafting | Independent t test p value | With bone impaction grafting | Without bone impaction grafting | Independent t test p value | |
| Harris hip score | 48 (15–81) (n = 46) | 50 (28–82) (n = 50) | 0.672 | 92 (35–100) (n = 72) | 96 (12–100) (n = 73) | 0.546 |
| Oxford Hip Questionnaire Score | 39 (30–52) (n = 9) | 38 (12–52) (n = 15) | 0.100 | 17 (12–45) (n = 70) | 15 (12–41) (n = 72) | 0.151 |
| VAS pain at rest | NA | NA | 0 (0–75) (n = 70) | 0 (0–70) (n = 71) | 0.260 | |
| VAS pain during physical activity | NA | NA | 10 (0–90) (n = 70) | 0 (0–100) (n = 71) | 0.267 | |
Values are expressed as median, with range in parentheses; VAS = visual analog scale; NA = not available.
Overview of the revised cups (n = 21)
| Patient | Years to revision | Cause | Part revised | Bone impaction grafting | Indication | Years to radiographic loosening | Previous hip operations |
|---|---|---|---|---|---|---|---|
| 5 | 7.3 | Infection | THA | No | Corticosteroids (systemic lupus erythematosus) | No | |
| 20 | 6.1 | Infection | THA | Yes | Avascular necrosis of unknown cause | Yes | |
| 50 | 5.7 | Infection | THA | No | Corticosteroids (Crohn’s Disease) | 2.6 | Yes |
| 68 | 8.1 | Infection | THA | No | Rheumatoid arthritis | No | |
| 87 | 5.3 | Infection | THA | No | Developmental dysplasia of the hip | 5.2 | Yes |
| 104 | 4 | Infection | THA | No | Corticosteroids (subarachnoid bleeding) | No | |
| 113 | 3.4 | Infection | THA | Yes | Corticosteroids (pituitary adenoma) | Yes | |
| 123 | 2.2 | Infection | THA | No | Medial column fracture | 0.5 | Yes |
| 111 | 8.6 | Recurrent dislocations | Cup | No | Posttraumatic coxarthrosis | No | |
| 160 | 3.5 | Recurrent dislocations | Cup | Yes | Corticosteroids (cerebral aneurysm) | Yes | |
| 84 | 10.3 | Traumatic loosening | THA | No | Corticosteroids (head trauma) | 9.9 | No |
| 29 | 4.1 | Aseptic loosening | Cup | Yes | Rheumatoid arthritis | 4 | No |
| 41 | 2.3 | Aseptic loosening | Cup | No | Corticosteroids (systemic lupus erythematosus) | 2.2 | Yes |
| 45 | 3.1 | Aseptic loosening | Cup | No | Spontaneous fusion of unknown cause | 0.3 | No |
| 49 | 1.1 | Aseptic loosening | Cup | No | Corticosteroids (kidney transplantation) | 4.2 | No |
| 77 | 16.8 | Aseptic loosening | Cup | Yes | Posttraumatic coxarthrosis | 16.6 | Yes |
| 78 | 9.8 | Aseptic loosening | Cup | Yes | Coxarthritis | 9.8 | Yes |
| 79 | 16.2 | Aseptic loosening | THA | Yes | Developmental dysplasia of the hip | 16.2 | No |
| 82 | 10 | Aseptic loosening | Cup | No | Developmental dysplasia of the hip | 5.2 | No |
| 90 | 6.4 | Aseptic loosening | THA | No | Developmental dysplasia of the hip | No | |
| 153 | 1.1 | Aseptic loosening | Cup | No | Epiphysiolysis | Yes |
Overview of complications
| Type of complication | Number |
|---|---|
| Intraoperative complications (n = 9) | |
| Entrapment of sciatic nerve during reposition, permanent damage | 1 |
| False route femur | 1 |
| Incomplete femoral fracture | 2 |
| Malposition cup | 1 |
| Malposition stem | 1 |
| Instrument failure | 1 |
| Suspicion of breakthrough of sterility | 2 |
| Postoperative complications (n = 30) | |
| Superficial wound infection | 3 |
| Single dislocation | 9 |
| Recurrent dislocations | 6 |
| Sensory nerve palsy | 4 |
| Sensory and motor nerve palsy | 1 |
| Hematoma | 6 |
| Bleeding after 4 months | 1 |
| Heterotopic ossifications (n = 44) | |
| Brooker Class I | 15 |
| Brooker Class II | 19 |
| Brooker Class III | 10 |
| Postoperative complications leading to revision (no cup revision) (n = 3) | |
| Stem revision for aseptic loosening | 1 |
| Head exchange because of recurrent dislocations | 2 |
| Postoperative complications requiring surgical intervention (no revision) (n = 7) | |
| Deep wound infection | 4 |
| Heterotopic ossifications | 1 |
| Traumatic dislocation | 1 |
| Persistent motor and sensory nerve palsy | 1 |
Radiographic findings of all cups*
| Radiographic finding | All | With bone impaction grafting | Without bone impaction grafting | p Value (where appropriate) |
|---|---|---|---|---|
| Radiographic loosening | 15 | 5 | 10 | 0.608 |
| Cup migration | 3 | 1 | 2 | 0.234 |
| Radiolucent lines | 58 | 18 | 40 | 0.02 |
| Zone I | 18 | 3 | 15 | 0.001 |
| Zone II | 2 | 0 | 2 | |
| Zone III | 17 | 9 | 8 | |
| Zones I + II | 4 | 2 | 2 | |
| Zones II + III | 5 | 2 | 3 | |
| Zones I + III | 5 | 1 | 4 | |
| Zones I + II + III | 7 | 1 | 6 | |
| Osteolysis | 11 | 5 | 6 | 0.861 |
| Zone I | 7 | 2 | 5 | |
| Zone II | 1 | 1 | 0 | |
| Zone III | 3 | 2 | 0 | |
| Cysts | 1 | 0 | 0 | 0.033 |
| Zone I | 1 | 0 | 0 | |
| Zone II | 0 | 0 | 0 | |
| Zone III | 0 | 0 | 0 | |
| Cup position | ||||
| Neutral position (35°–55°) | 160 | 77 | 83 | |
| Abnormal position | 15 | 7 | 8 | 0.914 |
| Vertical (> 55°) | 12 | 6 | 6 | |
| Horizontal (< 35°) | 3 | 1 | 2 | |
| Polyethylene wear | ||||
| Mean nonrevised cups (mm/year) | 0.080 | 0.076 | 0.084 | 0.539 |
| Mean revised cups (mm/year) | 0.214 | 0.182 | 0.230 | 0.525 |
* Total cups (n = 175); Cups with (n = 84) or without (n = 91) reconstruction with bone impaction grafting.
Fig. 1A–CThe radiographs illustrate reconstruction of the acetabuli in a 34-year-old woman with bilateral DDH (Crowe Grade 3). (A) A preoperative anteroposterior radiograph shows the acetabuli. (B) An anteroposterior radiograph taken immediately postoperatively shows the THAs with the acetabuli reconstructed with impaction grafting. (C) An anteroposterior radiograph taken 12 years postoperatively shows the THAs remain radiographically stable, but Brooker Classes III (left) and I (right) heterotopic ossifications are visible.
The 10-year survival rates*
| End point | All cups | Without bone impaction grafting | With bone impaction grafting | Log-rank p value |
|---|---|---|---|---|
| Revision for any reason | 85% (78%–92%) | 79% (68%–90%) | 91% (82%–99%) | 0.21 |
| Revision for any reason excluding infections | 91% (85%–97%) | 87% (78%–99%) | 94% (87%–100%) | 0.56 |
| Revision for aseptic loosening | 92% (87%–98%) | 90% (81%–99%) | 95% (89%–100%) | 0.73 |
* Kaplan-Meier estimates; 95% confidence interval in parentheses.
Fig. 2A–BKaplan-Meier survival curves with 95% confidence intervals (broken lines) of all cups with end points of (A) revision for any reason and (B) revision for aseptic loosening are shown. The vertical bars indicate the censored data points.
Fig. 3A–BKaplan-Meier survival curves of cups without impaction grafting (thick broken line, 95% confidence intervals in thin broken lines) and cups with impaction grafting (thick solid line, 95% confidence intervals in thin solid lines) with end points of (A) revision for any reason and (B) revision for aseptic loosening are shown.
Reported outcomes of the Harris hip score in patients < 40 years for primary THA
| Study | Questionnaire | Preoperative score | Postoperative score | Paired t-test p value |
|---|---|---|---|---|
| Chiu et al. [ | Harris hip score | 44 (26-74) | 88 (74-99) | < 0.001 |
| Duffy et al. [ | Harris hip score | 51 | 92 | < 0.001 |
| Current study | ||||
| With bone impaction grafting | Harris hip score | 48 (15–81) | 92 (35–100) | < 0.001 |
| Without bone impaction grafting | Harris hip score | 50 (28–82) | 96 (12–100) | < 0.001 |
Values are expressed as median (current study) or means (other studies), with range in parentheses.
Long-term acetabular cup survival rates in patients younger than 40 years
| Study | Number of hips | Age (years)* | Followup (years)* | Type of cup | Survival† | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 years | 7 years | 10 years | 15 years | 20 years | 25 years | 30 years | |||||
| Uncemented | |||||||||||
| Bizot et al. [ | 87 | 32.3 (17–40) | 7.7 (0–19)‡ | Screw-in alumina insert | 94.7 (68.5–99.2) | 88.8 (62.0–97.1) | 88.8 (62.0–97.1) | ||||
| Cerapress alumina | 100 | 95.1 (69.8–99.3) | |||||||||
| Cerafit alumina | 100 | 94.3 (66.3–99.2) | |||||||||
| Duffy et al. [ | 82 | 32 (17–39) | 10.3 (10–14) | PCA, Osteonics, H-G porous | Aseptic: 84.6 (76–93) | ||||||
| Excl inf: 81.8 (73–91) | |||||||||||
| McAuley et al. [ | 256 | 33.2 (16–40) | 7.3 (0–19) | Duraloc, AML, Arthropor, Triloc, H-G, Solution | 97.4 (SE 2.2) | 87.6 (SE 6.0) | 53.8 (SE 13.9) | ||||
| Odent et al. [ | 62 | 18.3 (11.8–31) | 6 (3–13) | Zweymuller | 90.1 (SE 7.1) | ||||||
| Cemented | |||||||||||
| Bizot et al. [ | 41 | 32.3 (17–40) | 7.7 (0–19)‡ | Plain alumina | 97.3 (81.9–99.6) | 94.1 (78.1–98.5) | 90.4 (73.0–96.8) | 78.9 (54.7–91.1) | |||
| Chiu et al. [ | 47§ | 28.8 (17–39) | 14.9 (7–21) | Charnley polyethylene | 86.3 (75.5–97.1) | 27.0 (10.7–43.3) | |||||
| Chmell et al. [ | 66 | 19.9 (11–29) | 15.1 (11–22) | Trapezoidal, Aufranc-Turner, custom-made | Aseptic: 98 (SE 1.6) | Aseptic: 97 (SE 2.8) | Aseptic: 84.5 (SE 4.7) | Aseptic: 70 (SE 7.3) | Aseptic: 40 (SE 15.6) | ||
| Joshi et al. [ | 218 | 32 (17–39) | 16 (10–24) | Charnley polyethylene | Aseptic: 99 (SE 0.5) | Aseptic: 96 (SE 1.4) | Aseptic: 91 (SE 2.3) | Aseptic: 84 (SE 4.6) | |||
| Sochart and Porter [ | 226 | 31.7 (17–39) | 19.7 (2–30) | Charnley polyethylene | 93 (90–96) | 71 (65–77) | 68 (61–75) | ||||
| Sochart and Porter [ | 83 | 24.9 (17–29) | 20 (5.2–30) | Charnley | 92 (85–98) | 70 (60–81) | 68 (57–79) | ||||
| Sochart and Porter [ | 43 | 28.8 (19–39) | 22.4 (0.1–30.3) | Charnley | 73 (61–84) | 70 (57–83) | |||||
| Current study | 175 | 31.0 (16–39) | 8.1 (2.0–18.5) | Exeter, Charnley, Müller/AlloPro | 85 (78–92) | ||||||
| With impacted bone grafts | 91 (83–99) | ||||||||||
Studies published through 2007; *Values are expressed as mean, with range in parentheses; †values are expressed as percentage, with 95% confidence interval in parentheses; ‡deceased and revised excluded; §lost to followup, deceased excluded, only Chinese patients; AML = anatomic medullary locking; PCA = porous-coated anatomic; Excl inf = excluding infections; H-G = Harris-Galante; SE = standard error.